481 related articles for article (PubMed ID: 35328471)
1. Immune Dysregulation in Autism Spectrum Disorder: What Do We Know about It?
Robinson-Agramonte MLA; Noris García E; Fraga Guerra J; Vega Hurtado Y; Antonucci N; Semprún-Hernández N; Schultz S; Siniscalco D
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328471
[TBL] [Abstract][Full Text] [Related]
2. Crosstalk Between the Microbiome and Gestational Immunity in Autism-Related Disorders.
Paysour MJ; Bolte AC; Lukens JR
DNA Cell Biol; 2019 May; 38(5):405-409. PubMed ID: 30817175
[TBL] [Abstract][Full Text] [Related]
3. A pilot study of high-dose intravenous immunoglobulin 5% for autism: Impact on autism spectrum and markers of neuroinflammation.
Melamed IR; Heffron M; Testori A; Lipe K
Autism Res; 2018 Mar; 11(3):421-433. PubMed ID: 29427532
[TBL] [Abstract][Full Text] [Related]
4. Immune Abnormalities in Autism Spectrum Disorder-Could They Hold Promise for Causative Treatment?
Gładysz D; Krzywdzińska A; Hozyasz KK
Mol Neurobiol; 2018 Aug; 55(8):6387-6435. PubMed ID: 29307081
[TBL] [Abstract][Full Text] [Related]
5. Cytokine expression profiles in Autism spectrum disorder: A multi-center study from Turkey.
Kutuk MO; Tufan E; Gokcen C; Kilicaslan F; Karadag M; Mutluer T; Yektas C; Coban N; Kandemir H; Buber A; Coskun S; Acikbas U; Guler G; Topal Z; Celik F; Altintas E; Giray A; Aka Y; Kutuk O
Cytokine; 2020 Sep; 133():155152. PubMed ID: 32563959
[TBL] [Abstract][Full Text] [Related]
6. Peripheral Auditory Nerve Impairment in a Mouse Model of Syndromic Autism.
McChesney N; Barth JL; Rumschlag JA; Tan J; Harrington AJ; Noble KV; McClaskey CM; Elvis P; Vaena SG; Romeo MJ; Harris KC; Cowan CW; Lang H
J Neurosci; 2022 Oct; 42(42):8002-8018. PubMed ID: 36180228
[TBL] [Abstract][Full Text] [Related]
7. Innate immune dysfunction and neuroinflammation in autism spectrum disorder (ASD).
Hughes HK; R J Moreno ; Ashwood P
Brain Behav Immun; 2023 Feb; 108():245-254. PubMed ID: 36494048
[TBL] [Abstract][Full Text] [Related]
8. The Association Between Somatic Health, Autism Spectrum Disorder, and Autistic Traits.
Pan PY; Tammimies K; Bölte S
Behav Genet; 2020 Jul; 50(4):233-246. PubMed ID: 31811521
[TBL] [Abstract][Full Text] [Related]
9. The immune response in autism: a new frontier for autism research.
Ashwood P; Wills S; Van de Water J
J Leukoc Biol; 2006 Jul; 80(1):1-15. PubMed ID: 16698940
[TBL] [Abstract][Full Text] [Related]
10. Impaired neurodevelopmental pathways in autism spectrum disorder: a review of signaling mechanisms and crosstalk.
Kumar S; Reynolds K; Ji Y; Gu R; Rai S; Zhou CJ
J Neurodev Disord; 2019 Jun; 11(1):10. PubMed ID: 31202261
[TBL] [Abstract][Full Text] [Related]
11. Beyond infection - Maternal immune activation by environmental factors, microglial development, and relevance for autism spectrum disorders.
Bilbo SD; Block CL; Bolton JL; Hanamsagar R; Tran PK
Exp Neurol; 2018 Jan; 299(Pt A):241-251. PubMed ID: 28698032
[TBL] [Abstract][Full Text] [Related]
12. Cellular and molecular mechanisms underlying autism spectrum disorders and associated comorbidities: A pathophysiological review.
Al Dera H
Biomed Pharmacother; 2022 Apr; 148():112688. PubMed ID: 35149383
[TBL] [Abstract][Full Text] [Related]
13. Investigation of the Relation between Epithelial Barrier Function and Autism Symptom Severity in Children with Autism Spectrum Disorder.
Nalbant K; Erden S; Yazar A; Kılınç İ
J Mol Neurosci; 2022 Apr; 72(4):741-747. PubMed ID: 34988901
[TBL] [Abstract][Full Text] [Related]
14. Neuro-Inflammatory Mechanisms in Developmental Disorders Associated with Intellectual Disability and Autism Spectrum Disorder: A Neuro- Immune Perspective.
Di Marco B; Bonaccorso CM; Aloisi E; D'Antoni S; Catania MV
CNS Neurol Disord Drug Targets; 2016; 15(4):448-63. PubMed ID: 26996174
[TBL] [Abstract][Full Text] [Related]
15. The Role of the Immune System in Autism Spectrum Disorder.
Meltzer A; Van de Water J
Neuropsychopharmacology; 2017 Jan; 42(1):284-298. PubMed ID: 27534269
[TBL] [Abstract][Full Text] [Related]
16. Decreased transforming growth factor beta1 in autism: a potential link between immune dysregulation and impairment in clinical behavioral outcomes.
Ashwood P; Enstrom A; Krakowiak P; Hertz-Picciotto I; Hansen RL; Croen LA; Ozonoff S; Pessah IN; Van de Water J
J Neuroimmunol; 2008 Nov; 204(1-2):149-53. PubMed ID: 18762342
[TBL] [Abstract][Full Text] [Related]
17. Environmental influence on neurodevelopmental disorders: Potential association of heavy metal exposure and autism.
Ijomone OM; Olung NF; Akingbade GT; Okoh COA; Aschner M
J Trace Elem Med Biol; 2020 Dec; 62():126638. PubMed ID: 32891009
[TBL] [Abstract][Full Text] [Related]
18. Dysregulation of Neurite Outgrowth and Cell Migration in Autism and Other Neurodevelopmental Disorders.
Prem S; Millonig JH; DiCicco-Bloom E
Adv Neurobiol; 2020; 25():109-153. PubMed ID: 32578146
[TBL] [Abstract][Full Text] [Related]
19. Immunological findings in autism.
Cohly HH; Panja A
Int Rev Neurobiol; 2005; 71():317-41. PubMed ID: 16512356
[TBL] [Abstract][Full Text] [Related]
20. Behavioral phenotypes and neurobiological mechanisms in the Shank1 mouse model for autism spectrum disorder: A translational perspective.
Sungur AÖ; Schwarting RKW; Wöhr M
Behav Brain Res; 2018 Oct; 352():46-61. PubMed ID: 28963042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]